Evidence map›Paper›PMID 42569856›Full record

ReviewCancer control : journal of the Moffitt Cancer Center

Population-Based Gastric Cancer Screening in Japan: Evolution, Challenges, and Lessons for Implementation.

Fumiaki Ishibashi, Nobutake Yamamichi, Taishi Okumura, Chikamasa Ichita, Katsuro Ichimasa, Masashi Misawa, Chika Kusano, Manami Inoue, Kazuo Ohtsuka, Takuji Gotoda

Abstract readReview
In one paragraph

Review in Cancer control : journal of the Moffitt Cancer Center. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Fumiaki IshibashiDigestive Disease Center, Showa Medical University Northern Yokohama Hospital, Kanagawa, Japan.ORCID 0000-0003-4065-7958
Nobutake YamamichiCenter for Epidemiology and Preventive Medicine, The University of Tokyo Hospital, Tokyo, Japan.
Taishi OkumuraDigestive Disease Center, Showa Medical University Northern Yokohama Hospital, Kanagawa, Japan.
Chikamasa IchitaDepartment of Gastroenterology, Kitasato University School of Medicine, Kanagawa, Japan.ORCID 0000-0001-9210-7371
Katsuro IchimasaDigestive Disease Center, Showa Medical University Northern Yokohama Hospital, Kanagawa, Japan.
Masashi MisawaDigestive Disease Center, Showa Medical University Northern Yokohama Hospital, Kanagawa, Japan.
Chika KusanoDepartment of Gastroenterology, Kitasato University School of Medicine, Kanagawa, Japan.
Manami InoueGraduate School of Public Health, St. Luke's International University, Tokyo, Japan.ORCID 0000-0003-1276-2398
Kazuo OhtsukaDigestive Disease Center, Showa Medical University Northern Yokohama Hospital, Kanagawa, Japan.
Takuji GotodaDepartment of Gastroenterology, Cancer Institute Hospital, Tokyo, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Japan has developed one of the world's most established population-based gastric cancer screening systems through more than six decades of continuous refinement in public health policy, technological innovation, and quality assurance. This review summarizes the historical development, technological evolution, quality assurance framework, and future perspectives of gastric cancer screening in Japan, while providing comparisons with major gastric cancer screening programs and prevention initiatives worldwide. Japanese gastric cancer screening can be traced to the postwar adaptation of mass tuberculosis radiographic screening systems, followed by the nationwide implementation of double-contrast upper gastrointestinal radiography. Subsequent advances in gastrointestinal endoscopy, including high-resolution imaging, magnifying endoscopy, and image-enhanced endoscopy, have facilitated the transition toward endoscopic screening and improved early gastric cancer detection. Japan has also established highly standardized quality assurance systems, including structured training, credentialing, standardized examination protocols, defined quality indicators, and continuous program monitoring of screening performance. These efforts have supported the standardization and continuous quality improvement of population-based gastric cancer screening programs. The incidence and risk-factor profile of gastric cancer are changing rapidly because of declining

Indexed as

Early Detection of CancerMass ScreeningStomach NeoplasmsHumansJapanendoscopygastric cancerJapanpopulation-based screeningupper gastrointestinal series

Identifiers

PMID42569856
PMCPMC13452933

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.